Cargando…
Precision Treatment in ACS–Role of Assessing Fibrinolysis
Despite advancements in pharmacotherapy and interventional strategies, patients with acute coronary syndrome (ACS) remain at risk of recurrent thrombotic events. In addition to an enhanced tendency to thrombus formation, impairment in the ability to naturally dissolve or lyse a developing thrombus,...
Autores principales: | Gue, Ying X., Jeong, Young-Hoon, Farag, Mohamed, Spinthakis, Nikolaos, Gorog, Diana A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957496/ https://www.ncbi.nlm.nih.gov/pubmed/33804303 http://dx.doi.org/10.3390/jcm10050929 |
Ejemplares similares
-
Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture
por: Spinthakis, Nikolaos, et al.
Publicado: (2019) -
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
por: Spinthakis, Nikolaos, et al.
Publicado: (2019) -
Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation
por: Gue, Ying X., et al.
Publicado: (2017) -
Fibrinolysis in Platelet Thrombi
por: Kanji, Rahim, et al.
Publicado: (2021) -
More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy—Current Data and Future Directions
por: Spinthakis, Nikolaos, et al.
Publicado: (2018)